Business

Ocumetics Announces Completion of New Injector Delivery System for the Ocumetics Accommodative Intraocular Lens

(TheNewswire) Calgary, Alberta – TheNewswire - August 8, 2024 - Ocumetic...

articleOcumetics Technology CorpAugust 8, 20244/company/ocumetics-technology-corp/news/ocumetics-announces-completion-of-new-injector-delivery-system-for-the-ocumetics-accommodative-intraocular-lens
Ocumetics Announces Completion of New Injector Delivery System for the Ocumetics Accommodative Intraocular Lens

About this update from Ocumetics Technology Corp

[{"type":"text","content":"Ocumetics Announces Completion of New Injector Delivery System for the Ocumetics Accommodative Intraocular Lens\n\n\n (TheNewswire)\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Calgary, Alberta\n \n\n –\n \n\n TheNewswire -\n \n\n August 8, 2024 - Ocumetics Technology Corp. (“\n \n\n Ocumetics\n \n\n ”)\n(\n \n\n TSXV: OTC) (OTCQB: OTCFF) (FRA: 2QBO), a\npioneer in vision enhancement technology, is excited to announce the\nsuccessful development of a new injector system specifically designed\nfor implantation of the Ocumetics Accommodative Intraocular lens (the\n“Ocumetics Lens”).  This achievement marks a significant\nmilestone in Ocumetics’ journey toward its first-in-human study\nscheduled for early 2025.\n \n\n\n\n The new injector, meticulously crafted by Medicil, a\nrenowned Swiss IOL (intraocular lens) injector manufacturer, is\ntailored to the unique specifications of the Ocumetics Lens, ensuring\nprecise and efficient implantation.  This development is crucial for\noptimizing the surgical procedure, performance, and patient outcomes\nof this innovative lens, which is designed to provide optimal visual\nperformance at all distances and improved quality of life for\nindividuals with visually significant cataracts.\n \n\n\n\n “We are delighted to have completed the development\nof this specialized injector in collaboration with Medicil,” said\nDean Burns, CEO of Ocumetics.  “Their expertise and commitment to\nquality have been instrumental in achieving this milestone.  This\nadvancement brings us one step closer to our goal of revolutionizing\nvision correction after cataract surgery with the Ocumetics\nAccommodative IOL.”\n \n\n\n\n “We are proud to partner with Medicil on this\ngroundbreaking project,” said Dr Garth Webb, Chief Scientist at\nOcumetics.  “Our team has worked diligently to develop an injector\nthat meets the high standards that are part of our corporate culture\nat Ocumetics.  We are excited to envision the potential impact this\nmight have on the field of ophthalmology.”\n \n\n\n\n The development of the Ocumetics Lens injector is a\npivotal step in preparation for the upcoming first-in-human study.  \nThis study, scheduled for early next year, is designed to evalu...

More updates from Ocumetics Technology Corp